Abstract
The effect of Lactiplantibacillus plantarum PGB02 isolated from buttermilk on serum cholesterol profile of normal and hypercholesterolemic mice was evaluated. Further changes in the expression of mice genes were determined. The hypercholesterolemia was induced in experimental mice by feeding high cholesterol and fat diet. Serum cholesterol parameters, physical parameters, cholic acid excretion, and cholesterol metabolism related gene expression analysis was carried out. L. plantarum PGB02 efficiently reduced total cholesterol, triglycerides, and LDL-cholesterol and improved HDL-cholesterol in hypercholesterolaemic mice. Body weight was reduced and fecal cholic acid increased in probiotic treatment groups. Gene expression analysis revealed that L. plantarum PGB02 up-regulated the expression of LDL receptors, CYP7A1, ABCA1, ABCG5, ABCG8, and down-regulated the expression of FXR and NPC1L1 genes. Summarizing the mechanism, L. plantarum PGB02 improved hypercholesterolemia by increasing bile acid synthesis and excretion, reducing exogeneous cholesterol absorption from the intestine, and increased LDL clearance through upregulation of LDL-receptors. The present study has given insight into the mechanism of serum cholesterol reduction by bile salt hydrolase positive L. plantarum PGB02 in mice. L. plantarum PGB02 reduced the serum cholesterol level through increased bile acid synthesis and deconjugation and reduced absorption of cholesterol in the intestine. Isolate PGB02 shown cholesterol removal potential as good as statin.
Similar content being viewed by others
Data Availability
There are no additional datasets associated with this study.
References
WHO. (2021). fact sheet, Cardiovascular diseases (CVDs). https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 7 May 2022.
Michael, D. R., et al. (2017). The anti-cholesterolaemic effect of a consortium of probiotics: An acute study in C57BL/6J mice. Science and Reports, 7, 1–10. https://doi.org/10.1038/s41598-017-02889-5
Banach, M., et al. (2015). Statin intolerance - an attempt at a unified definition. Archives of Medical Science, 11, 1–23. https://doi.org/10.5114/aoms.2015.49807
Kumar, M., et al. (2013). Probiotic Lactobacillus rhamnosus GG and Aloe vera gel improve lipid profiles in hypercholesterolemic rats. Nutrition, 29, 574–579. https://doi.org/10.1016/j.nut.2012.09.006
Fabian, E., & Elmadfa, I. (2006). Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women. Annals of Nutrition & Metabolism, 50, 387–393. https://doi.org/10.1159/000094304
Marteau, P. (2001). Safety aspects of probiotic products. Näringsforskning, 45, 22–24. https://doi.org/10.3402/fnr.v45i0.1785
Pereira, D. I. A., & Gibson, G. R. (2002). Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Applied and Environment Microbiology, 68, 4689–4693. https://doi.org/10.1128/AEM.68.9.4689-4693.2002
Rani, R. P., Anandharaj, M., & Ravindran, A. D. (2017). Characterization of bile salt hydrolase from Lactobacillus gasseri FR4 and demonstration of its substrate specificity and inhibitory mechanism using molecular docking analysis. Frontiers in Microbiology, 8, 1–13. https://doi.org/10.3389/fmicb.2017.01004
Liong, M. T., & Shah, N. P. (2006). Effects of a Lactobacillus casei synbiotic on serum lipoprotein, intestinal microflora, and organic acids in rats. Journal of Dairy Science, 89, 1390–1399. https://doi.org/10.3168/JDS.S0022-0302(06)72207-X
De Preter, V. et al. (2007). Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans, American Journal of Physiology-Gastrointestinal and Liver Physiology, 292. https://doi.org/10.1152/AJPGI.00052.2006
Pereira, D. I. A., & Gibson, G. R. (2002). Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Critical Reviews in Biochemistry and Molecular Biology, 37, 259–281. https://doi.org/10.1080/10409230290771519
Choi, S. B., Lew, L. C., Yeo, S. K., Parvathy, S. N., & Liong, M. T. (2015). Probiotics and the BSH-related cholesterol lowering mechanism: A Jekyll and Hyde scenario. Critical Reviews in Biotechnology, 35, 392–401. https://doi.org/10.3109/07388551.2014.889077
Lew, L. C., et al. (2018). Lactobacillus plantarum DR7 reduces cholesterol via phosphorylation of AMPK that down-regulated the mRNA expression of HMG-CoA reductase. Korean Journal for Food Science of Animal Resources, 38, 350. https://doi.org/10.5851/KOSFA.2018.38.2.350
Xu, G. et al. (2004). Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated. American Journal of Physiology. Gastrointestinal and Liver Physiology, 286. https://doi.org/10.1152/AJPGI.00397.2003
Huang, Y., & Zheng, Y. (2010). The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells. British Journal of Nutrition, 103, 473–478. https://doi.org/10.1017/S0007114509991991
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499–502. https://doi.org/10.1093/clinchem/18.6.499
Kumar, R., Grover, S., & Batish, V. K. (2011). Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague-Dawley rats. British Journal of Nutrition, 105, 561–573. https://doi.org/10.1017/S0007114510003740
Jeun, J., et al. (2010). Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice. Nutrition, 26, 321–330. https://doi.org/10.1016/j.nut.2009.04.011
Yan, F., et al. (2019). Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice. Food & Function, 10, 5804–5815. https://doi.org/10.1039/C9FO01062A
Clayton, P. T. (1998). Disorders of cholesterol biosynthesis. Archives of Disease in Childhood, 78, 185–189. https://doi.org/10.1136/adc.78.2.185
McCrindle, B. W., Ose, L., & Marais, A. D. (2003). Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: A multicenter, randomized, placebo-controlled trial. Journal of Pediatrics, 143, 74–80. https://doi.org/10.1016/S0022-3476(03)00186-0
Silverman, M. G., et al. (2016). Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: A systematic review and meta-analysis, JAMA -. Journal of the American Medical Association, 316, 1289–1297. https://doi.org/10.1001/jama.2016.13985
Chand, D., et al. (2017). Molecular features of bile salt hydrolases and relevance in human health. Biochim. Biophys. Acta - Gen. Subj., 1861, 2981–2991. https://doi.org/10.1016/j.bbagen.2016.09.024
Cohen, J. C., et al. (1992). Cloning of the human cholesterol 7α-hydroxylase gene (CYP7) and localization to chromosome 8q11–q12. Genomics, 14, 153–161. https://doi.org/10.1016/S0888-7543(05)80298-8
Angelin, B., Hershont, K. S., & Brunzellt, J. D. (1987). Bile acid metabolism in hereditary forms of hypertriglyceridemia: Evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia. Proceedings of the National Academy of Sciences, 84, 5434–5438. https://doi.org/10.1073/pnas.84.15.5434
Bell, G. D., Lewis, B., Petrie, A., & Dowling, R. H. (1973). Serum lipids in cholelithiasis: Effect of chenodeoxycholic acid therapy. British Medical Journal, 3, 520–523. https://doi.org/10.1136/BMJ.3.5879.520
Bateson, M., Maclean, D., Evans, J., & Bouchier, I. (1978). Chenodeoxycholic acid therapy for hypertriglyceridaemia in men. British Journal of Clinical Pharmacology, 5, 249–254. https://doi.org/10.1111/J.1365-2125.1978.TB01632.X
Crouse, J. R. (1987). Hypertriglyceridemia: A contraindication to the use of bile acid binding resins. American Journal of Medicine, 83, 243–248. https://doi.org/10.1016/0002-9343(87)90692-9
Beil, U., Crouse, J. R., Einarsson, K., & Grundy, S. M. (1982). Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides. Metabolism, 31, 438–444. https://doi.org/10.1016/0026-0495(82)90231-1
Young, S. G., & Fielding, C. J. (1999). The ABCs of cholesterol efflux. Nature Genetics, 22, 316–318. https://doi.org/10.1038/11878
Rust, S., et al. (1999). Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nature Genetics, 22, 352–355. https://doi.org/10.1038/11921
Jiao, Y., Lu, Y., & Li, X. Y. (2015). Farnesoid X receptor: A master regulator of hepatic triglyceride and glucose homeostasis. Acta Pharmacologica Sinica., 36, 44–50. https://doi.org/10.1038/aps.2014.116
DiMarzio, M. et al. (2017) Identification of a mouse Lactobacillus johnsonii strain with deconjugase activity against the FXR antagonist T-β-MCA. PLoS ONE, 12.https://doi.org/10.1371/journal.pone.0183564
Sinal, C. J., et al. (2000). Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell, 102, 731–744. https://doi.org/10.1016/S0092-8674(00)00062-3
Zein, A. A., Kaur, R., Hussein, T. O. K., Graf, G. A., & Lee, J.-Y. (2019). ABCG5/G8: A structural view to pathophysiology of the hepatobiliary cholesterol secretion. Biochemical Society Transactions, 47, 1259–1268. https://doi.org/10.1042/BST20190130
Degirolamo, C., Rainaldi, S., Bovenga, F., Murzilli, S., & Moschetta, A. (2014). Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Reports, 7, 12–18. https://doi.org/10.1016/j.celrep.2014.02.032
Liang, X., et al. (2020). Probiotics improved hyperlipidemia in mice induced by a high cholesterol diet via downregulating FXR. Food and Function, 11, 9903–9911. https://doi.org/10.1039/D0FO02255A
Martoni, C. J., Labbé, A., Ganopolsky, J. G., Prakash, S., & Jones, M. L. (2015). Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242. Gut Microbes, 6, 57–65. https://doi.org/10.1080/19490976.2015.1005474
Author information
Authors and Affiliations
Contributions
Hiren Dhameliya: conceptualization, methodology, and manuscript preparation; Jyoti Solanki: methodology and work-plan preparation; Dhaval Patel: methodology and conceptualization; Linz-buoy George: methodology and supervision; Vasudev Thakkar: supervision and validation; R. B. Subramanian: conceptualization, reviewing and editing.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Ethics Approval
The study protocol was approved by Institutional Animal Ethics Committee, under registration No. 167/199/CPCSEA from the Committee for the Purpose of Control and Supervision of Experiments on Animals, Delhi, India.
Consent to Participate
Not applicable.
Consent to Publish
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Dhameliya, H.A., Solanki, J.D., Patel, D.T. et al. Lactiplantibacillus plantarum PGB02 Improved Serum Cholesterol Profile by Tweaking Genes Involved in Cholesterol Homeostasis in Male Swiss Albino Mice. Appl Biochem Biotechnol 195, 3180–3193 (2023). https://doi.org/10.1007/s12010-022-04307-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-022-04307-7